2m 2m 2m 2m 2m 2m 2m
Agios Pharm (AGIO)
NASDAQ
$31.81-$0.67 (-2.06%)
Price as of Oct 02, 2026 5:07 PM EDT- $1.9BMarket Cap
- -18.66%1-Year Change
- BiotechnologyIndustry
Agios Pharm (AGIO)
$31.81-$0.67 (-2.06%)
AGIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.48 | ||
Change | -$0.77 (-2.32%) | ||
Open | $33.25 | ||
High | $33.73 | ||
Low | $32.42 | ||
Previous Close | $33.25 | ||
Volume | 1,703,750 | ||
30-Day Average Volume | 999,839 | ||
1-Week Change | -1.28% | ||
1-Month Change | -5.06% | ||
1-Year Change | -18.66% | ||
3-Year Change | 31.23% | ||
5-Year Change | -29.91% | ||
Fundamentals | |||
Shares Outstanding | 59.7M | ||
Total Assets | $1.1B | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $44.7M | ||
Net Income | -$100.7M | ||
Free Cash Flow | -$58.5M | ||
EBIT | -$100.7M | ||
EBITDA | -$99.4M | ||
Net Working Capital | $647.5M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 41 | ||
P/B | 2 | ||
P/E | -19 | ||
PEG | N/A | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue